EN DE
Watch GridAI Technologies Corp. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

GridAI Technologies Corp. (GRDX) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of GridAI Technologies Corp. stock $2.78, price $3.30, that is 15.8% below the price, quality 25 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Based in United Kingdom · ISIN US33749P5070

GT GridAI Technologies Corp. logo Thin data Nov 10, 2026

GridAI Technologies Corp.

GRDX · US

Expensive (fair value 16% below the price) and weak company, but rising price: meets 1 of 3 rules.

Get notified free when this changes
Rising price (uptrend) 
Ranks above peers (3/5) 
Fair value $2.78 · Overvalued 
Quality 25/100 
Weak Growth 
Negative free cash flow 
Narrow moat 12/100
Thin data 
Estimate
Watch GridAI Technologies Corp. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$87,444 $0.7140 Fair Value $2.78 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range $0.7140 – $87,444 · fair‑value band $2.08 – $3.47 · the $3.30 price screens above the $2.78 fair value. As of Nov 10, 2026.

Follow GridAI Technologies in your weekly email

Every Wednesday you see whether GridAI Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources.

Show moreShow less

It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Stock analysis

GridAI Technologies Corp. (GRDX) currently trades at $3.30, while our estimate is $2.78, 16% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $2.08 (bear) to $3.47 (bull), the price of $3.30 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 25/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

GridAI Technologies Corp. reported revenue of $36.3K in FY2025 versus $0 in FY2021. Reported net income was −$6.4M in FY2025.

Key figures

Market cap $29.3M Micro · EPS (TTM) $−5.65 · Return on assets (EBIT) −199% (5-year average) · Free cash flow −$5.7M · Net debt $1.4M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).

What moves the price

The share trades about 51% below its 52-week high and 65% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −16%, GRDX screens richer than that median.

Fair Value

Bear $2.08 Fair Value $2.78 Bull $3.47
Price $3.30 · Downside -15.8%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 25/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 75
Are margins and returns getting better?
Cashflow 9
Do the profits arrive as real cash?
Financial strength 43
Debt, balance sheet and risk of trouble
Investment 33
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 33
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 25
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

Plus 8 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

GRDX screens overvalued: fair value 16% below the price. Compare with Vertex Pharmaceuticals Incorporated →

Compare GridAI Technologies Corp. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 847 stocks

Beats the industry median on 2/3 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 25 · Bottom 25%
Fair Value upside −15.8% · Above median
Profitability
Return on assets −12.9% · Above median

Valuation Multiplesvs Biotechnology median · lower = cheaper

P/B 1.24× · book value is mostly intangible assets ⓘGoodwill and other intangible assets (such as prices paid for past acquisitions, brands, licences or film and series rights) are larger than the equity. So we do not rank this P/B against the peer group.

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)12 · sector 0
FUTURE (revenue growth)0 · sector 36
PAST (return on equity)0 · sector 0
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 21

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Biotechnology stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Regeneron Pharmaceuticals, Inc REGN $952.40 $1,275 +34% vs GRDX
Vertex Pharmaceuticals Incorporated VRTX $537.79 $592.46 +10% vs GRDX
Samsung Biologics Co 207940 1,423,000 KRW 1,552,100 KRW +9% vs GRDX
argenx SE ARGX $950.95 $908.40 −4% vs GRDX
CSL Limited CSL A$199.55 A$186.49 −7% vs GRDX
Moderna, Inc MRNA $215.27 $135.64 −37% vs GRDX
BeOne Medicines AG 6160 HK$249.40 HK$152.92 −39% vs GRDX
Revolution Medicines, Inc RVMD $166.87 $88.78 −47% vs GRDX
Celltrion, Inc 068270 214,500 KRW 74,945 KRW −65% vs GRDX
Royalty Pharma plc RPRX $68.53 $19.01 −72% vs GRDX

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

GridAI Technologies Corp.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "GridAI Technologies Corp. Fair Value". https://www.fairvalue-calculator.com/stock/GRDX

Frequently asked questions

Is GridAI Technologies Corp. (GRDX) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $2.78 versus a price of $3.30, about 16% lower (overvalued).
What is the fair value of GRDX?
Our estimate for GridAI Technologies Corp. is $2.78 (as of Nov 10, 2026), built from audited fundamentals. The current price: $3.30.
What is the quality score of GRDX?
GridAI Technologies Corp. has a Quality Score of 25/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for GridAI Technologies Corp. (GRDX)?
Our calculated price target is the estimate of $2.78 (as of Nov 10, 2026). Cautious scenario $2.08, optimistic scenario $3.47. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the GridAI Technologies Corp. stock forecast for 2026?
Our estimate puts fair value at $2.78, about 16% lower versus a price of $3.30 (overvalued). Cautious scenario $2.08, optimistic scenario $3.47. The calculation is refreshed regularly with new filings.
What is the intrinsic value of GridAI Technologies Corp. (GRDX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For GridAI Technologies Corp. it is $2.78 per share (as of Nov 10, 2026), against a price of $3.30.
Is GridAI Technologies Corp. stock overvalued or undervalued in 2026?
As of Nov 10, 2026, GRDX trades above its calculated fair value: price $3.30, fair value $2.78, a gap of about −16% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GRDX?
No. The price is what the market pays today ($3.30); the fair value is what the company's own numbers justify ($2.78). For GridAI Technologies Corp. the two are $0.5200 per share apart. That gap is exactly why we show both numbers side by side.
How much is GridAI Technologies Corp. worth?
The market values GridAI Technologies Corp. at about $29.3M (market capitalisation, as of Nov 10, 2026). Per share that is $3.30; our models calculate a fair value of $2.78 per share.
What do the bullish and bearish scenarios say about GRDX?
Our models span a range for GridAI Technologies Corp.: cautious scenario $2.08, base $2.78, optimistic $3.47 per share (as of Nov 10, 2026, price $3.30). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is GRDX from its 52-week high?
GridAI Technologies Corp. trades at $3.30, about 51% below its 52-week high of $6.80 and 65% above the low of $2.01 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of $2.78 is for.
Which stocks are comparable to GridAI Technologies Corp.?
From the same area (Healthcare) we also value Vertex Pharmaceuticals Incorporated, Moderna, Inc, Regeneron Pharmaceuticals, Inc, CSL Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is GridAI Technologies Corp. stock attractive at the current price?
The data as of Nov 10, 2026: price $3.30, calculated fair value $2.78 (−16%), Quality Score 25/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. GridAI Technologies Corp. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of GridAI Technologies Corp. (GRDX)?
The closing price on Nov 16, 2026 was $3.30. Our estimate is $2.78, about 16% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with GridAI Technologies Corp. right now?
Weak quality (25/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of GridAI Technologies Corp.

How large is the market capitalisation of GridAI Technologies Corp. (GRDX)?
The market capitalisation of GridAI Technologies Corp. is $29.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of GridAI Technologies Corp. (GRDX)?
Earnings per share at GridAI Technologies Corp. are $−5.65. Earnings per share over the last twelve months: total profit spread across every single share.
What is the EBIT return on assets of GridAI Technologies Corp. (GRDX)?
On an EBIT basis the return on assets of GridAI Technologies Corp. is −199% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does GridAI Technologies Corp. (GRDX) generate?
The free cash flow of GridAI Technologies Corp. is −$5.7M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does GridAI Technologies Corp. (GRDX) carry?
The net debt of GridAI Technologies Corp. is $1.4M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch GridAI Technologies Corp. in the live analysis

One click puts GridAI Technologies Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.